Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by KayDayon Jan 19, 2011 7:49pm
504 Views
Post# 17999056

News

NewsWith any luck we will get news tomorrow though I am expecting Monday.  For everyone to consider...  Every time I spoke to Alan or others they have told me that it does not matter what this trial is called, it will be a Phase III.  For example it is very likely that the trial will start off as another Phase IIb and transition into a Phase III.  Be prepared for this possibility!!!  It is all the same thing and normal, it does NOT change anything.
There is so much news coming... the next few months should be fun!  Good luck everyone.
Bullboard Posts